Clinical Trial Update: Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a combined therapy (F520) with lenvatinib for advanced solid tumors across Phase 1 and Phase 2, with no current status informa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• F520
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN